Search Results for: svf

Cell Surgical Network Series Part 3: Key Concerns

Elliot-Lander-and-Mark-berman-300x2331

I recently interviewed Drs. Elliot Lander and Mark Berman of the Cell Surgical Network. It’s an affiliated chain of clinics selling stem cell interventions for more than a dozen medical conditions. You can read Part 1 here and Part 2 here of the interview where we cover 10 important questions. Today is Part 3, where I explain why their answers

Cell Surgical Network Series Part 3: Key Concerns Read More »

Elliot Lander & Mark Berman Interview Part 1: A Window into Cell Surgical Network

The Cell Surgical Network is a large and growing group of affiliated stem cell clinics across the US. The Network providers use stromal vascular fraction (SVF) interventions for a host of conditions on a for-profit basis. Drs. Elliot Lander and Mark Berman lead the Network. They agreed to do a Q&A interview with me. Below is Part 1,

Elliot Lander & Mark Berman Interview Part 1: A Window into Cell Surgical Network Read More »

The funny list of phony & possible future stem cell journals

Stem-Cell-Enquirer1-226x300

Recently I posted a piece on a list of stem cell journals that is growing longer by the day. Below for fun I’ve made up some new names of stem cell journals possibly of the future. I’ve also in some cases included commentary. I have a feeling that some of these may become real in coming years

The funny list of phony & possible future stem cell journals Read More »

Time to bone up on homologous use in the stem cell field

What does homologous use mean? Navigating the arena of clinical use of a biologic such as stem cells or differentiated cells made from stem cells can be challenging. There are many important issues including what defines “minimal manipulation” of biologics such as cells. One particular issue that is critically important and has drawn less attention

Time to bone up on homologous use in the stem cell field Read More »

Celltex FDA FOIA letter #2: no safety concerns with our stem cells, which really are not drugs

A FOIA request that I made with the FDA in mid-December 2012 has at long last revealed  letters from Celltex  to the FDA that previously were not in the public domain. The reason for the FOIA and for these blog posts is to shed some light on important issues that particularly relate to patient safety. I

Celltex FDA FOIA letter #2: no safety concerns with our stem cells, which really are not drugs Read More »

Intellicell Inspected By FDA: What Does It Mean?

IntelliCell (SVFC) is a stem cell company that does cosmetic stem cell procedures. They’ve had a number of challenges of late including an FDA warning letter about a year ago and apparent financial issues manifesting in lawsuits. Now the company itself, perhaps trying to get ahead of the news, issued a press release (PR) saying they

Intellicell Inspected By FDA: What Does It Mean? Read More »

Jury is still out on purported adult pluripotent stem cells despite new MUSE paper

MUSE-cells

Are MUSE cells for real? Stem cells come in different types that vary in a key property called “potency”, but very few are pluripotent. The more potency, the greater the flexibility of a stem cell to make other cell types. Flexibility in the cellular world is power. The most powerful stem cells generally used are

Jury is still out on purported adult pluripotent stem cells despite new MUSE paper Read More »

Stem cell company Intellicell facing new financial wrinkles

Intellicell

It’s difficult to make it as a biotech company, I would say stem cell biotechs in general may have an even rougher time, and one such company,  Intellicell (Intellicell Biosciences, Inc), is showing a number of signs of distress in my opinion. An online financial tool predicts the probability of companies going bankrupt within the next

Stem cell company Intellicell facing new financial wrinkles Read More »